Publications produced by the EDRN investigators.
The following is a list of publications authored by EDRN investigators. You may sort and filter the results by both author and journal.
. Deregulated EGFR signaling during lung cancer progression: Mutations, amplicons, and autocrine loops
—Gazdar AF, Minna JD
. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.
—Maresh EL, Pietras R, Marquez D, Zhang L, Chia D, Fishbein MC, Mah V, Yoon N, Bagryanova L, Alavi M, Horvath S, Goodglick L.
. Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.
—Li A, Bonavida B, Elshimali Y, Maresh E, Chia D, Seligson DB, Mah V, Yoon NK, Goodglick L., Sulur G, Horvath S, Bose S
2-D or not 2-D is there a fututre for 2-D gels in proteomics? Insights from the York proteomic meeting
2D Differential In-gel Electrophoresis (DIGE) for the Identification of Esophageal Squamous Cell Cancer-Specific Protein Markers
—Hu N, Gong Y, Emmert-Buck MR, Gillespie JW, Chen S, Zhou G, DeCamp D, Taylor PR, Liotta LA, Shu H, Zhao Y, Petricoin III EF, Li H, Flaig M
4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene
—Feng Z, Beland FA, Tang M-s, Hu W, Rom WN
[-2]proPSA for prostate cancer detection: an NCI Early Detection Research Network validation study.
—Thompson IM, Wang Y, Sokoll LJ, Partin AW, Sanda MG, Feng Z, Kagan J, Chan DW
A blood-based proteomic classifier for the molecular characterization of pulmonary nodules
—Fang KC, Allard R, Pass H, Kearney P, Massion PP, Fong PY, Schirm M, Price ND, Hunsucker SW, Chelsky D, Lam S, Hood L, Vachani A, Lamontagne J, Rom WN, Dominguez M, Law S, Gingras O, Lee LW, Hayward C, McLean M, Li XJ, Butler H
A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens.
A data-analytic strategy for protein-biomarker discovery: profiling of high-dimensional proteomic data for cancer detection
—Winget M, Potter JD, Wright G Jr, Adam B-L, Thompson ML, Feng Z, Pepe M, Yasui Y, Thornquist M, Qu Y
A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis
—Misek DE, Le Naour F, Hanash SM and Beretta L, Brechot C, Brichory F
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.
A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States
—van der Klift H, de la Chapelle A, Lynch JF, Fodde R, Okimoto R, Sweet K, Franken P, Lynch HT, Coronel SM, Barrows A, Wagnr A, Wijnen J, Hampel H
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
A functional annotation of subproteomes in human plasma
—Chaerkady R, Pandey A, Peri S, Molina H, Drwal G, Gronborg M, Yang Z, Wasinger V, Kwon MS, Menon R, Paik YK, States DJ, Hanash SM, Rekha B, Hancock WS, Shet AS, Suresh S, Kellmann M, Gandhi TK, Gerszten RE, Raftery M, Cho SY, Schulz-Knappe P, Wu H, Vondriska TM, Creighton CJ, Omenn GS, Ping P
A functional arginine residue in NADPH-dependent aldehyde reductase from pig kidney.
A functional link between adhesion and proteolysis in ovarian epithelial ovarian carcinoma cells
—Bafetti LM, Fishman DA, Stack MS, Kearns A
A genetic analysis of extinction: Trans-dominant loci regulate expression of liver-specific genes in hepatoma hybrid cells
—Fournier REK, Killary AM
A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.
A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum
—Srivastava S, Camp DG, Qian WJ, Nicora CD, Su D, Liu T, Rodland KD, Shi T, Liu AY, Zhao R, Fillmore TL, Quek SI, Kagan J, Gao Y, Smith RD, Chan DW